Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents
Pablo Montejano-Hervás, Javier Gómez‐Pavón, Olga Tornero-Torres, Ma Victoria Valverde-Moyar, Beatriz Martín Cruz, Maribel Vela Carbonera, Raquel Fuentes-Irigoyen, Pilar Tejada González, Margarita González-Becerra, Esther Higueras Sánchez, Primitivo Ramos Cordero
Topics & Concepts
MedicineVaccinationAdverse effectObservational studyIncidence (geometry)PopulationImmunogenicityEmergency medicinePediatricsInternal medicineImmunologyEnvironmental healthPhysicsOpticsImmune systemSARS-CoV-2 and COVID-19 ResearchGeriatric Care and Nursing HomesInfluenza Virus Research Studies